Genelux GNLX
NASDAQ GNLX
$1.98 -0.09 (-4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genelux (GNLX) Short-term Investments (2023 - 2025)

Updated

Genelux's Short-term Investments came in at $16.22 million for Q3 2025, down 42.0% from $27.96 million a year earlier and down 24.3% from the prior quarter.

Analysis

Genelux (GNLX) Short-term Investments (2023 - 2025) Analysis & Trends

At the end of FY2024, Genelux's Short-term Investments was $22.33 million, up 62.1% from FY2023.

  • Going back by year, Short-term Investments was $13.77 million in FY2023.
  • The Q3 2025 figure represents the lowest quarterly Short-term Investments since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Genelux 88.78 Mn 27.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 16.22 Mn
Jun 30, 2025 21.43 Mn
Dec 31, 2024 22.33 Mn
Sep 30, 2024 27.96 Mn
Jun 30, 2024 25.78 Mn
Mar 31, 2024 15.57 Mn
Dec 31, 2023 13.77 Mn
API Access

Genelux Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=GNLX&period=max&api_key=YOUR_API_KEY